Floatz logo

Ginkgolide

Nervous System Disorder

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

35 Active assets in the Nervous System Disorder cohort.

Asset / SponsorPhaseRating
Guanfacine
Maimonides Medical Center
Phase 4BB
Opc-34712
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3BB
Live Combined Bifidobacterium,Lactobacillus And Enterococcus Capsules
Beijing Friendship Hospital
Phase 4BB
3-N-BUTYLPHTHALIDE
Qianfoshan Hospital
Phase 4BB
D-thioctic acid
Ain Shams University
Phase 4BB

View all 50 →

Same molecule, other indications

Ginkgolide is also rated in:

Intravenous Alteplase ThrombolysisDormant
BB
Indicative ·
69 / 100
View asset →
Ischemic StrokeDormant
B
Indicative ·
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →